This is due to the noticeable elevation of IL-2 in the plasma of many patients with severe COVID-19 (6, 19, 20), and high-dose IL-2 administration causes capillary leak syndrome (21, 22), a severe clinical manifestations of CRS (23). This evidence concerns the gene IL2 and COVID-19.